BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tauschmann M, Hovorka R. Technology in the management of type 1 diabetes mellitus - current status and future prospects. Nat Rev Endocrinol 2018;14:464-75. [PMID: 29946127 DOI: 10.1038/s41574-018-0044-y] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Knebel T, Neumiller JJ. Medtronic MiniMed 670G Hybrid Closed-Loop System. Clin Diabetes 2019;37:94-5. [PMID: 30705505 DOI: 10.2337/cd18-0067] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 3.8] [Reference Citation Analysis]
2 Matsumoto A, Chen S. A boronate gel-based synthetic platform for closed-loop insulin delivery systems. Polym J 2021;53:1305-14. [DOI: 10.1038/s41428-021-00525-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li Y, Ji W, Peng H, Zhao R, Zhang T, Lu Z, Yang J, Liu R, Zhang X. Charge-switchable zwitterionic polycarboxybetaine particle as an intestinal permeation enhancer for efficient oral insulin delivery. Theranostics 2021;11:4452-66. [PMID: 33754071 DOI: 10.7150/thno.54176] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Leelarathna L, Thabit H, Wilinska ME, Bally L, Mader JK, Pieber TR, Benesch C, Arnolds S, Johnson T, Heinemann L, Hermanns N, Evans ML, Hovorka R. Evaluating Glucose Control With a Novel Composite Continuous Glucose Monitoring Index. J Diabetes Sci Technol 2020;14:277-83. [PMID: 30931606 DOI: 10.1177/1932296819838525] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
5 Li BY, Xu XY, Gan RY, Sun QC, Meng JM, Shang A, Mao QQ, Li HB. Targeting Gut Microbiota for the Prevention and Management of Diabetes Mellitus by Dietary Natural Products. Foods. 2019;8. [PMID: 31557941 DOI: 10.3390/foods8100440] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
6 Li J, He Q, Abdulhay E. Evaluation of Tresiba Combined with Six Ingredient Rehmannia Pill in the Treatment of Type 2 Diabetes. Journal of Healthcare Engineering 2022;2022:1-6. [DOI: 10.1155/2022/2177176] [Reference Citation Analysis]
7 Morsada Z, Hossain MM, Islam MT, Mobin MA, Saha S. Recent progress in biodegradable and bioresorbable materials: From passive implants to active electronics. Applied Materials Today 2021;25:101257. [DOI: 10.1016/j.apmt.2021.101257] [Reference Citation Analysis]
8 Leahy JJL, Aleppo G, Fonseca VA, Garg SK, Hirsch IB, McCall AL, McGill JB, Polonsky WH. Optimizing Postprandial Glucose Management in Adults With Insulin-Requiring Diabetes: Report and Recommendations. J Endocr Soc 2019;3:1942-57. [PMID: 31608313 DOI: 10.1210/js.2019-00222] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
9 Leelarathna L, Choudhary P, Wilmot EG, Lumb A, Street T, Kar P, Ng SM. Hybrid closed-loop therapy: Where are we in 2021? Diabetes Obes Metab 2021;23:655-60. [PMID: 33269551 DOI: 10.1111/dom.14273] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
10 Takahashi H, Sakata N, Yoshimatsu G, Hasegawa S, Kodama S. Regenerative and Transplantation Medicine: Cellular Therapy Using Adipose Tissue-Derived Mesenchymal Stromal Cells for Type 1 Diabetes Mellitus. J Clin Med 2019;8:E249. [PMID: 30781427 DOI: 10.3390/jcm8020249] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
11 Dos Santos TJ, Donado Campos JM, Fraga Medin CA, Argente J, Rodríguez-Artalejo F. New insulin delivery devices and glycemic outcomes in young patients with type 1 diabetes: a protocol for a systematic review and meta-analysis. Syst Rev 2019;8:259. [PMID: 31685014 DOI: 10.1186/s13643-019-1171-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 . MUW researcher of the month. Wien Klin Wochenschr 2020;132:274-5. [PMID: 32462503 DOI: 10.1007/s00508-020-01674-1] [Reference Citation Analysis]
13 Major S, El Fathi A, Palisaitis E, Kearney R, Von Oettingen JE, Krishnamoorthy P, Legault L, Haidar A. Postprandial hyperglycaemia following insulin suspensions by the artificial pancreas: Implications for bolus calculators. Diabetes Obes Metab 2020;22:1474-7. [PMID: 32533655 DOI: 10.1111/dom.14044] [Reference Citation Analysis]
14 Longo M, Caruso P, Petrizzo M, Castaldo F, Sarnataro A, Gicchino M, Bellastella G, Esposito K, Maiorino MI. Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy. Diabetes Res Clin Pract. 2020;169:108440. [PMID: 32926958 DOI: 10.1016/j.diabres.2020.108440] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
15 Armgarth A, Pantzare S, Arven P, Lassnig R, Jinno H, Gabrielsson EO, Kifle Y, Cherian D, Arbring Sjöström T, Berthou G, Dowling J, Someya T, Wikner JJ, Gustafsson G, Simon DT, Berggren M. A digital nervous system aiming toward personalized IoT healthcare. Sci Rep 2021;11:7757. [PMID: 33833303 DOI: 10.1038/s41598-021-87177-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Agarwal S, Crespo-Ramos G, Leung SL, Finnan M, Park T, McCurdy K, Gonzalez J, Long JA. Solutions to Address Inequity in Diabetes Technology Use in Type 1 Diabetes: Results from Multidisciplinary Stakeholder Co-Creation Workshops. Diabetes Technol Ther 2022. [PMID: 35138944 DOI: 10.1089/dia.2021.0496] [Reference Citation Analysis]
17 Wu Z, Luo S, Zheng X, Bi Y, Xu W, Yan J, Yang D, Weng J. Use of a do-it-yourself artificial pancreas system is associated with better glucose management and higher quality of life among adults with type 1 diabetes. Ther Adv Endocrinol Metab 2020;11:2042018820950146. [PMID: 32922721 DOI: 10.1177/2042018820950146] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
18 Dos Santos TJ, Dave C, MacLeish S, Wood JR. Diabetes technologies for children and adolescents with type 1 diabetes are highly dependent on coverage and reimbursement: results from a worldwide survey. BMJ Open Diabetes Res Care 2021;9:e002537. [PMID: 34845060 DOI: 10.1136/bmjdrc-2021-002537] [Reference Citation Analysis]
19 Fernández JM, García-seco JA. COMMERCIALIZED HYBRID CLOSED-LOOP SYSTEM (MINIMED MEDTRONIC 670G) RESULTS DURING PREGNANCY. Endocrine Practice 2020. [DOI: 10.1016/j.eprac.2020.11.019] [Reference Citation Analysis]
20 Yang SN, Berggren PO. The eye as a novel imaging site in diabetes research. Pharmacol Ther 2019;197:103-21. [PMID: 30677477 DOI: 10.1016/j.pharmthera.2019.01.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
21 Cha GD, Kang D, Lee J, Kim D. Bioresorbable Electronic Implants: History, Materials, Fabrication, Devices, and Clinical Applications. Adv Healthcare Mater 2019;8:1801660. [DOI: 10.1002/adhm.201801660] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 14.0] [Reference Citation Analysis]
22 Šumník Z, Pavlíková M, Pomahačová R, Venháčová P, Petruželková L, Škvor J, Neumann D, Vosáhlo J, Konečná P, Čížek J, Strnadel J, Průhová Š, Cinek O; ČENDA Project Group. Use of continuous glucose monitoring and its association with type 1 diabetes control in children over the first 3 years of reimbursement approval: Population data from the ČENDA registry. Pediatr Diabetes 2021;22:439-47. [PMID: 33533545 DOI: 10.1111/pedi.13184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Bittenglova K, Habart D, Saudek F, Koblas T. The Potential of Pancreatic Organoids for Diabetes Research and Therapy. Islets 2021;13:85-105. [PMID: 34523383 DOI: 10.1080/19382014.2021.1941555] [Reference Citation Analysis]
24 Leroux G, Neumann M, Meunier CF, Michiels C, Wang L, Su B. Alginate@TiO2 hybrid microcapsules as a reservoir of beta INS-1E cells with controlled insulin delivery. J Mater Sci 2020;55:7857-69. [DOI: 10.1007/s10853-020-04576-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Schütz-Fuhrmann I, Rami-Merhar B, Hofer SE, Fröhlich-Reiterer E, Mader J, Stadler M, Bischof M, Zlamal-Fortunat S, Laimer M, Weitgasser R. [CGM-Continuous Glucose Monitoring-Statement of the Austrian Diabetes Association (Update 2019)]. Wien Klin Wochenschr 2019;131:119-23. [PMID: 30980171 DOI: 10.1007/s00508-019-1465-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Gajewska KA, Biesma R, Bennett K, Sreenan S. Barriers and facilitators to accessing insulin pump therapy by adults with type 1 diabetes mellitus: a qualitative study. Acta Diabetol 2021;58:93-105. [PMID: 32862261 DOI: 10.1007/s00592-020-01595-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
27 Haidar A, Legault L, Raffray M, Gouchie-Provencher N, Jacobs PG, El-Fathi A, Rutkowski J, Messier V, Rabasa-Lhoret R. Comparison Between Closed-Loop Insulin Delivery System (the Artificial Pancreas) and Sensor-Augmented Pump Therapy: A Randomized-Controlled Crossover Trial. Diabetes Technol Ther 2021;23:168-74. [PMID: 33050728 DOI: 10.1089/dia.2020.0365] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
28 Marcovecchio ML, Dalton RN, Daneman D, Deanfield J, Jones TW, Neil HAW, Dunger DB; Adolescent type 1 Diabetes cardio-renal Intervention Trial (AdDIT) study group. A new strategy for vascular complications in young people with type 1 diabetes mellitus. Nat Rev Endocrinol 2019;15:429-35. [PMID: 30996294 DOI: 10.1038/s41574-019-0198-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
29 Sergeeva TY, Mukhitova RK, Nizameev IR, Kadirov MK, Sapunova AS, Voloshina AD, Mukhametzyanov TA, Ziganshina AY, Antipin IS. A Glucose-Responsive Polymer Nanocarrier Based on Sulfonated Resorcinarene for Controlled Insulin Delivery. Chempluschem 2019;84:1560-6. [PMID: 31943934 DOI: 10.1002/cplu.201900428] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Infante M, Baidal DA, Rickels MR, Fabbri A, Skyler JS, Alejandro R, Ricordi C. Dual-hormone artificial pancreas for management of type 1 diabetes: Recent progress and future directions. Artif Organs 2021;45:968-86. [PMID: 34263961 DOI: 10.1111/aor.14023] [Reference Citation Analysis]
31 Jin Q, Lin L, Zhao T, Yao X, Teng Y, Zhang D, Jin Y, Yang M. Overexpression of E3 ubiquitin ligase Cbl attenuates endothelial dysfunction in diabetes mellitus by inhibiting the JAK2/STAT4 signaling and Runx3-mediated H3K4me3. J Transl Med 2021;19:469. [PMID: 34798872 DOI: 10.1186/s12967-021-03069-w] [Reference Citation Analysis]
32 Tian J, Pan W, Xu X, Tian X, Zhang M, Hu Q. NF-κB inhibits the occurrence of type 1 diabetes through microRNA-150-dependent PUMA degradation. Life Sci 2020;255:117724. [PMID: 32360624 DOI: 10.1016/j.lfs.2020.117724] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Fuchs J, Hovorka R. Closed-loop control in insulin pumps for type-1 diabetes mellitus: safety and efficacy. Expert Rev Med Devices 2020;17:707-20. [PMID: 32569476 DOI: 10.1080/17434440.2020.1784724] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
34 Pu Z, Zhang X, Yu H, Tu J, Chen H, Liu Y, Su X, Wang R, Zhang L, Li D. A thermal activated and differential self-calibrated flexible epidermal biomicrofluidic device for wearable accurate blood glucose monitoring. Sci Adv 2021;7:eabd0199. [PMID: 33571117 DOI: 10.1126/sciadv.abd0199] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
35 Ergun-Longmire B, Clemente E, Vining-Maravolo P, Roberts C, Buth K, Greydanus DE. Diabetes education in pediatrics: How to survive diabetes. Dis Mon 2021;67:101153. [PMID: 33541707 DOI: 10.1016/j.disamonth.2021.101153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Lau HH, Gan SU, Lickert H, Shapiro AMJ, Lee KO, Teo AKK. Charting the next century of insulin replacement with cell and gene therapies. Med 2021;2:1138-62. [DOI: 10.1016/j.medj.2021.09.001] [Reference Citation Analysis]
37 Chiesa ST, Marcovecchio ML. Preventing Cardiovascular Complications in Type 1 Diabetes: The Need for a Lifetime Approach. Front Pediatr 2021;9:696499. [PMID: 34178905 DOI: 10.3389/fped.2021.696499] [Reference Citation Analysis]
38 Neves JC, Neves JS, Neves C, Carvalho D. Predictors of the effectiveness of insulin pumps in patients with type 1 diabetes mellitus. Endocrine 2021. [PMID: 34339007 DOI: 10.1007/s12020-021-02837-4] [Reference Citation Analysis]
39 Zeng Y, Wang J, Gu Z, Gu Z. Engineering glucose-responsive insulin. Medicine in Drug Discovery 2019;3:100010. [DOI: 10.1016/j.medidd.2019.100010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
40 Moreno-Fernández J, García-Seco JA. Commercialized Hybrid Closed-Loop System (Minimed Medtronic 670G) Results During Pregnancy. AACE Clin Case Rep 2021;7:177-9. [PMID: 34095482 DOI: 10.1016/j.aace.2020.11.039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
41 Dos Santos TJ, Donado Campos JM, Argente J, Rodríguez-Artalejo F. Effectiveness and equity of continuous subcutaneous insulin infusions in pediatric type 1 diabetes: A systematic review and meta-analysis of the literature. Diabetes Res Clin Pract 2021;172:108643. [PMID: 33359572 DOI: 10.1016/j.diabres.2020.108643] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Fu Q, Murray CI, Karpov OA, Van Eyk JE. Automated proteomic sample preparation: The key component for high throughput and quantitative mass spectrometry analysis. Mass Spectrom Rev 2021;:e21750. [PMID: 34786750 DOI: 10.1002/mas.21750] [Reference Citation Analysis]
43 Dos Santos TJ, Rodrigues TC, Puñales M, Arrais RF, Kopacek C. Newest Diabetes-Related Technologies for Pediatric Type 1 Diabetes and Its Impact on Routine Care: a Narrative Synthesis of the Literature. Curr Pediatr Rep 2021;:1-12. [PMID: 34430071 DOI: 10.1007/s40124-021-00248-7] [Reference Citation Analysis]
44 Martin LD, Hoagland MA, Rhodes ET, Wolfsdorf JI, Hamrick JL, Fehr J, Kim E, Tommerdahl K, Gleich SJ, O’reilly-shah V, Tosone S, Keech K, D’souza G, Honkanen A. Perioperative Management of Pediatric Patients With Type 1 Diabetes Mellitus, Updated Recommendations for Anesthesiologists: . Anesthesia & Analgesia 2020;130:821-7. [DOI: 10.1213/ane.0000000000004491] [Cited by in Crossref: 6] [Article Influence: 3.0] [Reference Citation Analysis]
45 Marks BE, Wolfsdorf JI. Monitoring of Pediatric Type 1 Diabetes. Front Endocrinol (Lausanne) 2020;11:128. [PMID: 32256447 DOI: 10.3389/fendo.2020.00128] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
46 Choe J, Won SH, Choe Y, Park SH, Lee YJ, Lee J, Lee YA, Lim HH, Yoo JH, Lee SY, Kim EY, Shin CH, Kim JH. Temporal Trends for Diabetes Management and Glycemic Control Between 2010 and 2019 in Korean Children and Adolescents with Type 1 Diabetes. Diabetes Technol Ther 2021. [PMID: 34704794 DOI: 10.1089/dia.2021.0274] [Reference Citation Analysis]
47 Regittnig W, Tschaikner M, Tuca AC, Simic A, Feiel J, Schaller-Ammann R, Licht AH, Jungklaus M, Pieber TR. Insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: Implications for insulin pump therapy. Diabetes Obes Metab 2021. [PMID: 34739179 DOI: 10.1111/dom.14594] [Reference Citation Analysis]
48 Di Bartolo P, Eckel RH. Living with Insulin: The story of insulin from people with diabetes. Diabetes Res Clin Pract 2021;176:108857. [PMID: 33965450 DOI: 10.1016/j.diabres.2021.108857] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Chen S, Miyazaki T, Itoh M, Matsumoto H, Moro-oka Y, Tanaka M, Miyahara Y, Suganami T, Matsumoto A. Temperature-Stable Boronate Gel-Based Microneedle Technology for Self-Regulated Insulin Delivery. ACS Appl Polym Mater 2020;2:2781-90. [DOI: 10.1021/acsapm.0c00341] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
50 Ilkowitz J, Wissing V, Gallagher MP. Pediatric Smart Insulin Pen Use: The Next Best Thing. J Diabetes Sci Technol 2021;:19322968211041362. [PMID: 34474591 DOI: 10.1177/19322968211041362] [Reference Citation Analysis]
51 Haidar A, Yale J, Lovblom LE, Cardinez N, Orszag A, Falappa CM, Gouchie‐provencher N, Tsoukas MA, El Fathi A, Rene J, Eldelekli D, Lanctôt SO, Scarr D, Perkins BA. Reducing the need for carbohydrate counting in type 1 diabetes using closed‐loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non‐inferiority, crossover pilot trial. Diabetes Obes Metab 2021;23:1272-81. [DOI: 10.1111/dom.14335] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
52 Malandrucco I, Russo B, Picconi F, Menduni M, Frontoni S. Glycemic Status Assessment by the Latest Glucose Monitoring Technologies. Int J Mol Sci 2020;21:E8243. [PMID: 33153229 DOI: 10.3390/ijms21218243] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
53 Lee YJ, Lee YA, Kim JH, Chung HR, Gu MJ, Kim JY, Shin CH. The durability and effectiveness of sensor-augmented insulin pump therapy in pediatric and young adult patients with type 1 diabetes. Ann Pediatr Endocrinol Metab 2020;25:248-55. [PMID: 33401881 DOI: 10.6065/apem.2040048.024] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
54 Commissariat PV, Roethke LC, Finnegan JL, Guo Z, Volkening LK, Butler DA, Dassau E, Weinzimer SA, Laffel LM. Youth and parent preferences for an ideal AP system: It is all about reducing burden. Pediatr Diabetes 2021. [PMID: 34324772 DOI: 10.1111/pedi.13252] [Reference Citation Analysis]
55 Lunati ME, Morpurgo PS, Rossi A, Gandolfi A, Cogliati I, Bolla AM, Plebani L, Vallone L, Montefusco L, Pastore I, Cimino V, Argenti S, Volpi G, Zuccotti GV, Fiorina P. Hybrid Close-Loop Systems Versus Predictive Low-Glucose Suspend and Sensor-Augmented Pump Therapy in Patients With Type 1 Diabetes: A Single-Center Cohort Study. Front Endocrinol 2022;13:816599. [DOI: 10.3389/fendo.2022.816599] [Reference Citation Analysis]
56 Manning ML, Singh H, Stoner K, Habif S. The Development and Psychometric Validation of the Diabetes Impact and Device Satisfaction Scale for Individuals with Type 1 Diabetes. J Diabetes Sci Technol 2020;14:309-17. [PMID: 32028790 DOI: 10.1177/1932296819897976] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]